These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 5050)

  • 21. Widespread emergence of Vibrio cholerae 0139 in India.
    Sachdeva V; Khanna KK; Singh M; Singh J; Kumari S; Verghese T
    Southeast Asian J Trop Med Public Health; 1995 Jun; 26(2):342-6. PubMed ID: 8629072
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Resistance of Vibrio cholerae 0:1 to the 0/129 compound and multiresistance to antibiotics].
    Bougoudogo F; Fournier JM; Gastellu-Etchegorry M; Guillou M; Dodin A
    Bull Soc Pathol Exot; 1992; 85(2):136-41. PubMed ID: 1327350
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Plasmid profiles and antimicrobial susceptibility patterns of Vibrio cholerae O1 strain isolated during a recent outbreak in Nigeria.
    Olukoya DK; Ogunjimi AA; Abaelu AM
    J Diarrhoeal Dis Res; 1995 Jun; 13(2):118-21. PubMed ID: 7594312
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Class 1 integrons and SXT elements conferring multidrug resistance in Vibrio cholerae O1 strains associated with a recent large cholera outbreak in Orissa, Eastern India.
    Jain M; Kumar P; Goel AK; Kamboj DV; Singh L
    Int J Antimicrob Agents; 2008 Nov; 32(5):459-60. PubMed ID: 18706789
    [No Abstract]   [Full Text] [Related]  

  • 25. Emergence and rapid spread of tetracycline-resistant Vibrio cholerae strains, Madagascar.
    Dromigny JA; Rakoto-Alson O; Rajaonatahina D; Migliani R; Ranjalahy J; Mauclére P
    Emerg Infect Dis; 2002 Mar; 8(3):336-8. PubMed ID: 11927038
    [No Abstract]   [Full Text] [Related]  

  • 26. [Use of a transposon determining tetracycline resistance (Tn10) in genetic studies of cholera vibrios].
    Smirnova NI; Il'ina TS; Goncharova NS; Smirnov GB
    Genetika; 1980; 16(10):1808-15. PubMed ID: 6257586
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Examination of the antibacterial action of metronidazole against vibrios and Campylobacter (author's transl)].
    Füzi M
    Zentralbl Bakteriol A; 1981; 249(2):242-6. PubMed ID: 7269853
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The resistance of cholera vibrios to antibiotics].
    Podosinnikova LS; Domaradskiĭ IV; Ermol'eva ZV; Ryzhko IV
    Antibiotiki; 1974 Mar; 19(3):219-23. PubMed ID: 4499703
    [No Abstract]   [Full Text] [Related]  

  • 29. [Evaluation of Vibrio cholerae isolation over 10 years in CHU Fann].
    Sow AI; Cisse MF; Sanou I; Diallo-Gaye A; Diop PD; Boye CS; Mboup S; Samb A
    Dakar Med; 1992; 37(2):113-6. PubMed ID: 1345081
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antibiotic sensitivity pattern of V. cholerae strains isolated in 1974.
    Datta A; Datta GC; Pal SC
    Indian J Med Res; 1976 Oct; 64(10):1432-4. PubMed ID: 1017856
    [No Abstract]   [Full Text] [Related]  

  • 31. Tetracycline resistant El Tor Vibrios in Loni area.
    Jain RC; Bhat BD; Basutkar SH
    J Assoc Physicians India; 1992 Sep; 40(9):636. PubMed ID: 1308032
    [No Abstract]   [Full Text] [Related]  

  • 32. Outbreak of cholera caused by Vibrio cholerae 01 intermediately resistant to norfloxacin at Malda, West Bengal.
    Bhattacharya MK; Ghosh S; Mukhopadhyay AK; Deb A; Bhattacharya SK
    J Indian Med Assoc; 2000 Jul; 98(7):389-90. PubMed ID: 11143861
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Potential for in vivo acquisition of R plasmids by one strain of Vibrio cholerae biotype El tor.
    Davey RB; Pittard J
    Antimicrob Agents Chemother; 1975 Aug; 8(2):111-6. PubMed ID: 1101813
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Comparative in vitro study of antibiotic resistance increase in classical cholera and E1 Tor vibrios].
    Ganin VS; Khundanov LE; Navashin SM
    Antibiotiki; 1971 Sep; 16(9):831-4. PubMed ID: 4333292
    [No Abstract]   [Full Text] [Related]  

  • 35. The characterization of Vibrio cholerae isolated in Kenya in 1983.
    Ichinose Y; Ehara M; Watanabe S; Shimodori S; Waiyaki PG; Kibue AM; Sang FC; Ngugi J; Kaviti JN
    J Trop Med Hyg; 1986 Oct; 89(5):269-76. PubMed ID: 3795327
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antibiotic resistance pattern of Vibrio cholerae and Shigella causing diarrhoea outbreaks in the eastern Africa region: 1994-1996.
    Materu SF; Lema OE; Mukunza HM; Adhiambo CG; Carter JY
    East Afr Med J; 1997 Mar; 74(3):193-7. PubMed ID: 9185422
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Selection of attenuated Vibrio cholerae strains to obtain oral attenuated candidate vaccines against cholera].
    María García H; Año G; Cedré B; Valmaseda T; Maestre JL; Díaz M; Mirabal M; Talavera A; García L
    Rev Cubana Med Trop; 2005; 57(2):92-104. PubMed ID: 17966578
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antibiotic-resistant Vibrio cholerae in Parangipettai coastal environs, south east India.
    Sathiyamurthy K; Purushothaman A; Ramaiyan V
    Microb Drug Resist; 1997; 3(3):267-70. PubMed ID: 9270997
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Resistance to antibiotics of vibrio cholerae strains isolated in Angola].
    Ferreira E; Costa M; Vaz Pato MV
    Pathol Biol (Paris); 1992 May; 40(5):561-5. PubMed ID: 1495844
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Features of Vibrio cholerae 0:1 El Tor, Inaba serotype, isolated during the cholera epidemic in Cartagena (Colombia)].
    Salim Máttar V
    Enferm Infecc Microbiol Clin; 1992 Nov; 10(9):525-30. PubMed ID: 1489792
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.